Bicycle Therapeutics plcBCYCNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank39
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P39
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -1.15% |
| Q2 2025 | -8.06% |
| Q1 2025 | -0.46% |
| Q4 2024 | 15.14% |
| Q3 2024 | 13.75% |
| Q2 2024 | -2.45% |
| Q1 2024 | 9.31% |
| Q4 2023 | -3.31% |
| Q3 2023 | 2.56% |
| Q2 2023 | 8.14% |
| Q1 2023 | 30.98% |
| Q4 2022 | 4.57% |
| Q3 2022 | -8.05% |
| Q2 2022 | -33.85% |
| Q1 2022 | 93.14% |
| Q4 2021 | 5.49% |
| Q3 2021 | 12.55% |
| Q2 2021 | -9.26% |
| Q1 2021 | -25.38% |
| Q4 2020 | 69.37% |
| Q3 2020 | 1.78% |
| Q2 2020 | 25.93% |
| Q1 2020 | 47.17% |
| Q4 2019 | -29.09% |
| Q3 2019 | 61.08% |
| Q2 2019 | -12.61% |
| Q1 2019 | 61.54% |
| Q4 2018 | -9.42% |
| Q3 2018 | 36.60% |
| Q2 2018 | -14.39% |
| Q1 2018 | -22.65% |
| Q4 2017 | 0.00% |